GAMMA Investing’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$47.4K Buy
1,325
+2
+0.2% +$70 ﹤0.01% 2402
2026
Q2
$41.5K Sell
1,323
-11
-0.8% -$464 ﹤0.01% 2426
2026
Q1
$73.8K Sell
1,334
-36
-3% -$1.71K ﹤0.01% 1887
2025
Q4
$51.2K Sell
1,370
-223
-14% -$9.06K ﹤0.01% 2069
2025
Q3
$64.5K Buy
1,593
+81
+5% +$2.67K ﹤0.01% 1821
2025
Q2
$38.6K Sell
1,512
-207
-12% -$4.51K ﹤0.01% 2081
2025
Q1
$36.7K Sell
1,719
-20
-1% -$447 ﹤0.01% 2014
2024
Q4
$36.5K Buy
1,739
+262
+18% +$6.06K ﹤0.01% 1910
2024
Q3
$33.3K Buy
1,477
+463
+46% +$8.94K ﹤0.01% 1771
2024
Q2
$17K Buy
1,014
+711
+235% +$11.4K ﹤0.01% 1958
2024
Q1
$3.92K Buy
303
+299
+7,475% +$3.58K ﹤0.01% 2516
2023
Q4
$43 Buy
+4
New +$45 ﹤0.01% 3164

Other funds holding PAHC

GAMMA Investing's PAHC Position: Q3 2026 in Review

GAMMA Investing increased its Phibro Animal Health (PAHC) stake by 0.15% in Q3 2026, buying an estimated $70 and bringing the position to 1,325 shares worth $47.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2402.

GAMMA Investing first reported a position in PAHC in Q4 2023 and has held it in 12 quarters since. The position peaked at $73.8K in Q1 2026. 10 funds tracked by Wall St. Rank hold PAHC as of Q3 2026.

  • GAMMA Investing held 1,325 shares of Phibro Animal Health worth $47.4K as of Q3 2026.
  • GAMMA Investing bought 2 Phibro Animal Health shares in Q3 2026, an estimated $70.
  • Phibro Animal Health made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #2402 holding.
  • GAMMA Investing first reported a position in Phibro Animal Health in Q4 2023 and has held it in 12 quarters since.
  • GAMMA Investing's Phibro Animal Health position peaked at $73.8K in Q1 2026.
  • 10 funds tracked by Wall St. Rank held Phibro Animal Health as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.